Eli Lilly (LLY) Current Taxes (2009 - 2025)

Eli Lilly has reported Current Taxes for 17 years, with the latest figure at $9.4 billion in Q3 2025.

• For the quarter ending Q3 2025, Current Taxes changed N/A year-over-year to $9.4 billion; the trailing twelve-month figure through Sep 2025 stood at $9.4 billion (changed N/A YoY), and the FY2024 full-year result was $1.1 billion, changed N/A from the prior year.
• Current Taxes for Q3 2025 stood at $9.4 billion, up from $7.0 billion in the prior quarter.
• The five-year high for Current Taxes was $9.4 billion in Q3 2025, with the low at $126.6 million in Q2 2022.
• Historically, Current Taxes has averaged $2.1 billion across 5 years, with a median of $791.6 million in 2021.
• Annual changes were most pronounced in 2021 — Current Taxes sank 82.66% — and 2023, when it jumped 874.57%.
• Eli Lilly's Current Taxes stood at $126.9 million in 2021, then surged by 274.39% to $475.1 million in 2022, then jumped by 316.23% to $2.0 billion in 2023, then plunged by 43.54% to $1.1 billion in 2024, then soared by 745.97% to $9.4 billion in 2025.
• The last three Current Taxes figures came in at $9.4 billion (Q3 2025), $7.0 billion (Q2 2025), and $6.2 billion (Q1 2025), per Business Quant data.